Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Bayer
The study has previously been posted by Schering AG, Germany. Schering AG, Germany has been renamed to Bayer Schering Pharma AG, Germany.
Bayer Schering Pharma AG, Germany is the sponsor of the trial.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Diagnosis of MS for no less than one year and no longer than ten years
Disease in the secondary progressive (SP) phase
At least one relapse the last 3 years
Treatment with an interferon for at least 6 months and with Betaferon for at least 3 months
You may not be if
Serious or acute heart disease
Severe depression
Serious or acute liver, kidney or bone marrow dysfunction
